Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Takeda discontinues US supply of gout drug Uloric over generic competition
3 months ago
Manufacturing
AstraZeneca allocates $570M for Canadian expansion, looks to add 700 new jobs
3 months ago
R&D
As another Trump term gets underway, pharma advisors get comfortable with uncertainty
3 months ago
FDA+
Teva, Astellas plan to participate in IRA drug price negotiations
3 months ago
FDA+
Purdue, Sacklers reach new $7.4B opioid settlement after SCOTUS rejection
3 months ago
Law
Teva’s MS drug and generics to add black box warning for anaphylaxis
3 months ago
AstraZeneca exec stresses Calquence's patent life ahead of next Medicare negotiations
3 months ago
FDA+
Vanda loses constitutional fight over FDA's drug talks with competitors
3 months ago
FDA+
Law
J&J reinforces Caplyta blockbuster projections, won't shelve neuro prospects
3 months ago
J&J’s Spravato hit $1B in revenue in 2024
3 months ago
US withdrawal from WHO could jeopardize information sharing
3 months ago
Renewed mifepristone fight will be early test of Trump’s abortion stance in his second term
3 months ago
Law
J&J's Spravato wins expanded label for depression as singular treatment
3 months ago
FDA+
Exiting Medicare director expects current law to guide next price negotiations
3 months ago
People
FDA+
Sage sues Biogen days after $469M buyout offer
3 months ago
Law
Novo claims high-dose Phase 3 Wegovy win but sales impact might be muted
3 months ago
R&D
Ozempic makes list for next round of Medicare drug price negotiations
3 months ago
After three-month delay, Amgen’s Lumakras clinches FDA green light in colorectal cancer
3 months ago
Roche's cardiometabolic chief warns against weight loss 'obsession' with GLP-1s
3 months ago
Teva says it has a 'unique position' in latest IRA challenge
3 months ago
Law
HHS blasts Boehringer's drug price case, reveals new details on Jardiance talks
3 months ago
Law
EMA in 2024 recommended highest number of drug approvals in 15 years
3 months ago
Novartis enters fight against HHS for denying its 340B rebate model
3 months ago
Law
Eli Lilly's Omvoh earns FDA approval for Crohn's disease
3 months ago
FDA+
First page
Previous page
14
15
16
17
18
19
20
Next page
Last page
